Drug recall
Platelets, Pathogen Reduced
FDA recall event 89354 · Class II · Rhode Island Blood Center, A Division of New York Blood Center, Inc.
Key facts
| Event ID | 89354 |
|---|---|
| Recall numbers | B-0155-2022 |
| Recalling firm | Rhode Island Blood Center, A Division of New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Platelets, Pathogen Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Platelet product, for which quality control for residual WBC count was not performed, was distributed. |
| Initiation date | Nov 29, 2021 |
| Report date | Jan 26, 2022 |
| Termination date | Jan 18, 2022 |
| City | Providence |
| State | RI |
| Country | United States |
| FEI number | 1270007 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: